PSNLPersonalis, Inc.
Services-Medical Laboratories
- Revenue
- $70M
- 18% YoY
- Operating margin
- -126.4%
- 57% YoY
- EBITDA
- −$78M
- 36% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- −$94M net debt
- AI in 10-K
- —
Red flags 1 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCFired14% of revenueOver 10% of revenue
- Payouts exceed cash flowClear0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear—Over 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $85M | $65M | $73M | $85M | $70M | 18% |
| Operating income | −$65M | −$116M | −$110M | −$68M | −$88M | 29% |
| Net income | −$65M | −$113M | −$108M | −$81M | −$81M | 0.0% |
| Operating cash flow | −$71M | −$70M | −$56M | −$45M | −$75M | 66% |
| Capex | $11M | $50M | $11M | $2M | $5M | 181% |
| Stock-based comp | $14M | $19M | $14M | $11M | $9M | 12% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $267K · 4
- Net
- −$267K
Pay vs performance
No pay-versus-performance disclosure yet.